# US 2022/0033875 A1 · Method For Assaying The Activity Of Spermidine/Spermine N1-Acetyltransferase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0033875 A1
- Document ID: US20220033875A1
- Status: Published application
- Kind: A1
- Application number: 17/406,956
- Filed: 2021-08-19
- Published: 2022-02-03
- Earliest claimed: 2011-11-16
- Assignees: BioMark Technologies Inc.
- Applicants: BioMark Technologies Inc.
- Inventors: Brian CHENG; Rashid BUX; Daniel SITAR
- Web page: https://patentgrep.com/patent/US20220033875A1

## CPC

- C12Q 1/48: involving transferase
- G01N 33/57557: {of other specific parts of the body, e.g. brain}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for assaying activity of the enzyme spermidine/spermine N1-acetyltransferase (SSAT) uses SSAT substrates by detecting their acetylated forms. SSAT substrates may include rimantadine and tocainide wherein their metabolism occurs in part by the action of the inducible enzyme SSAT to produce the acetylated metabolites N-acetylrimantadine and N-acetyltocainide respectively. SSAT activity may be correlated to pathologic conditions.

## Claims

### Claim 1

A method for determining activity of spermine/spermidine N1-acetyltransferase (SSAT) in a mammal, the method comprising:
(a) providing a biological sample from the mammal to which rimantadine or tocainide has been introduced;
(b) detecting or measuring the level of an acetylated metabolite of rimantadine or tocainide in the biological sample; and
(c) correlating a presence or level of the acetylated metabolite of rimantadine or tocainide in the biological sample to SSAT activity in the mammal.

### Claim 2 (depends on 1)

The method of claim 1, wherein: the biological sample in (a) is from a mammal to which rimantadine has been introduced; an acetylated metabolite of rimantadine is determined or measured in (b); and the presence or level of the acetylated metabolite of rimantadine in the biological sample is correlated to SSAT activity in (c).

### Claim 3 (depends on 1)

The method of claim 1, wherein: the biological sample in (a) is from a mammal to which tocainide has been introduced; an acetylated metabolite of tocainide is determined or measured in (b); and the presence or level of the acetylated metabolite of tocainide in the biological sample is correlated to SSAT activity in (c).

### Claim 4

A method for determining activity of spermine/spermidine N1-acetyltransferase (SSAT) in a mammal, the method comprising:
(a) incubating a cell from the mammal in a suitable cell culture;
(b) introducing rimantadine or tocainide to the cell culture;
(c) detecting a presence or measuring a level of an acetylated metabolite of rimantadine or tocainide in the cell culture; and
(d) correlating the presence or level of the acetylated metabolite of rimantadine or tocainide in the cell culture to SSAT activity in the mammal.

### Claim 5 (depends on 4)

The method of claim 4, wherein comprises obtaining a sample from the cell culture after introducing the rimantadine or the tocainide to the cell culture; and measuring an amount of an acetylated metabolite of the rimantadine or the tocainide in the sample.

### Claim 6 (depends on 4)

The method of claim 4, wherein the cell from the mammal is a hepatocyte.

### Claim 7 (depends on 4)

The method of claim 4, wherein: rimantadine is introduced in (b); an acetylated metabolite of rimantadine is detected or measured in (c); and the presence or level of the acetylated metabolite of rimantadine in the cell culture is correlated to SSAT activity in (d).

### Claim 8 (depends on 4)

The method of claim 4, wherein: tocainide is introduced in (b); an acetylated metabolite of tocainide is detected or measured in (c); and the presence or level of the acetylated metabolite of tocainide in the cell culture is correlated to SSAT activity in (d).
